Comparison
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063 vs 12p12 1 Microdeletion Syndrome C4755260
Clinical comparison between 17 Alpha Hydroxylase 7 20 Lyase Deficiency CN380063 and 12p12 1 Microdeletion Syndrome for differential diagnosis and treatment planning.
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
A rare genetic disorder affecting steroid hormone production. Causes ambiguous genitalia, lack of puberty, and high blood pressure. Requires lifelong hormone replacement therapy.
12p12 1 Microdeletion Syndrome C4755260
A rare chromosomal condition involving a small missing piece of chromosome 12. Features vary but may include developmental delays and congenital differences. Care involves monitoring and supportive interventions.
6 comparison axes
Onset
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
0-18
12p12 1 Microdeletion Syndrome C4755260
0-null
Onset patterns differ
Severity
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
severe
12p12 1 Microdeletion Syndrome C4755260
moderate
Different severity levels
Chronic
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
Chronic
12p12 1 Microdeletion Syndrome C4755260
Chronic
Differing course
Communicable
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
No
12p12 1 Microdeletion Syndrome C4755260
No
Different transmission
Body System
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
endocrine
12p12 1 Microdeletion Syndrome C4755260
congenital
Same/different system
Category
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
endocrine
12p12 1 Microdeletion Syndrome C4755260
genetic
Different category
Bottom line
17-alpha-hydroxylase-7-20-lyase-deficiency-CN380063 and 12p12-1-microdeletion-syndrome-C4755260 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063 | 12p12 1 Microdeletion Syndrome C4755260 | Discriminating power |
|---|---|---|---|
| Blood pressure | Hypertension is described and may begin in childhood or adolescence. | Hypertension is not a defining feature in the supplied description. | Moderate |
| Puberty and genital development | Ambiguous genitalia and absent puberty are reported. | Genital or pubertal findings are not specifically established here. | High |
| Development | Developmental delay is not a core described feature. | Developmental delay and congenital differences may occur and vary. | Moderate |
When to favor each condition
Choose 17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063 when
Hypertension with disordered puberty or atypical genitalia
These features align with impaired steroid hormone production.
Moderate
Suspected inherited steroid-synthesis disorder
The condition is described as a rare genetic endocrine disorder.
Moderate
Need for lifelong hormone replacement is being considered
Replacement is stated as required, but regimen must be clinician-directed.
High
Choose 12p12 1 Microdeletion Syndrome C4755260 when
Variable congenital anomalies with developmental delay
This pattern fits the described chromosomal microdeletion better than a primary steroid defect.
Moderate
Chromosomal testing suggests a small 12p12.1 deletion
The diagnosis depends on identifying the missing chromosomal segment.
High
Supportive monitoring is the main care need
The supplied description emphasizes monitoring and supportive interventions.
Moderate
How key tests differ
| Test | 17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063 | 12p12 1 Microdeletion Syndrome C4755260 | Interpretation |
|---|---|---|---|
| Steroid hormone evaluation | Abnormal steroid production is expected, but exact cutoffs are not supplied. | No characteristic steroid pattern is established. | Abnormal results support endocrine evaluation but do not alone prove the diagnosis. |
| Chromosomal microarray | A 12p12.1 deletion is not the described cause. | A small missing segment at 12p12.1 supports the syndrome. | Genetic confirmation should be interpreted by a qualified clinician or geneticist. |
| Blood pressure assessment | Hypertension may be present. | No specific blood-pressure pattern is established. | Blood pressure is a clinical clue, not a diagnostic test. |
Prognosis comparison
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
- Outcome
- A severe chronic endocrine course is described, but individual outcomes are not established.
- Factors
- Blood pressure, hormone balance, and specialist care may influence course.
12p12 1 Microdeletion Syndrome C4755260
- Outcome
- A moderate chronic course with variable features is described.
- Factors
- The specific deletion effects and developmental or congenital findings may influence needs.
Time frame: Both may require care from childhood onward; exact timelines are not established.
Prognosis should be individualized; comparative survival or complication rates are not supplied.
Complications comparison
| Complication | Presentation |
|---|---|
| Hypertension-related effects | High blood pressure is a recognized concern. Not established from the supplied data. Specific organ complications and rates should not be assumed. |
| Sex development and puberty | Ambiguous genitalia and lack of puberty may occur. Not specifically described. Individual anatomy and hormone findings require specialist assessment. |
| Developmental and congenital differences | Not described as core features. Delays and congenital differences may vary widely. The range and severity are not fully established here. |
Patient education highlights
- HighSpecialist follow-up
Both conditions need individualized clinician interpretation and long-term follow-up.
- HighHormone care
The endocrine condition is described as requiring lifelong hormone replacement; doses must not be self-adjusted.
- MediumVariable features
The microdeletion syndrome can differ between people, so one person’s findings do not predict another’s.